Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Zelira Therapeutics ( (AU:ZLD) ) just unveiled an announcement.
Zelira Therapeutics has secured a $1 million At-the-Market (ATM) funding facility with Securities Vault Pty Ltd to support its clinical programs and growth strategy. This facility provides Zelira with flexible access to equity capital over the next 12 months, allowing the company to align capital needs with operational activities while maintaining control over the timing and terms of capital issuances. The ATM agreement enhances Zelira’s financial flexibility and positions the company to advance its strategic objectives without incurring significant dilution or complex financing mechanisms.
More about Zelira Therapeutics
Zelira Therapeutics Ltd is a global leader in the development and commercialization of clinically validated cannabinoid-based medicines. The company focuses on advancing key clinical programs and implementing growth strategies in the cannabinoid medicine industry.
YTD Price Performance: -22.34%
Average Trading Volume: 380
Technical Sentiment Signal: Buy
Current Market Cap: $3.43M
Find detailed analytics on ZLD stock on TipRanks’ Stock Analysis page.